The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Cytokinetics, Incorporated(NASDAQ:CYTK) 
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is developing small molecule drug candidates primarily engineered to increase mu...
Website: http://www.cytokinetics.com
Founded: 1997
Full Time Employees: 156
Sector: Healthcare
Industry: Biotechnology
Cytokinetics Days Payable Outstanding ttm (DPO)
Cytokinetics Days Receivable Outstanding ttm (DSO)
Cytokinetics Days Inventory Outstanding ttm (DIO)
Cytokinetics Op Cashflow Per Share ttm
Cytokinetics Free Cashflow Per Share ttm
Cytokinetics Cash Per Share ttm
Cytokinetics P/S ratio ttm
Cytokinetics (GAAP) P/E ratio ttm
Cytokinetics P/B ratio ttm
No extra charts and metrics for this ticker.